According to an email received on (b)(6) 2018: "identified disease on the patient is mitral regurgitation and stenosis.The contribution factor of replacement was pseudoaneurysm on lv (left ventricle) accompanied by lv rupture.No infection was confirmed.According to the surgeon conducting the revision surgery, the explanting valve looks no problem at sight, but not sure of hidden issue and therefore he would like [manufacturer] to examine it in detail and provide an investigational report.".
|
A review of the manufacturing records revealed that the product met all specifications and passed all manufacturing test.Another review was held of the available information.The product was explanted on (b)(6) 2016.No date of implant is given hence duration of implant could not be calculated.Report from the field is that the patient experienced mitral regurgitation and stenosis as well as left ventricular (lv) pseudoaneurysm and lv rupture.No echocardiogram was given to verify these observations.There was no evidence of infection.Although the valve appeared normal on explant, the surgeon requested an analysis of the valve for any "hidden issue." the valve was returned and examined, minor non-obstructive tissue growth was noted on the perimeter of the inflow side.All manufacturing specifications were found to be within acceptable limits.Lv pseudoaneurysm is generally associated with myocardial infarction, but no other patient information is present to confirm or deny its contribution.Because the valve examination came back normal, no evidence was obtained to attribute the lv pseudoaneurysm and rupture to the valve performance.Consequently, no sufficient evidence to attribute what, if any, contribution the valve had to the development of stenosis, regurgitation, lv pseudoaneurysm, or lv rupture.In any case, heart failure, myocardial infarction, prosthesis nonstructural dysfunction, prosthesis regurgitation, and the possibility of reoperation and explantation are all acknowledged as potential adverse events in the products instructions for use.
|
According to an email received on (b)(6) 2018: "identified disease on the patient is mitral regurgitation and stenosis.The contribution factor of replacement was pseudoaneurysm on lv (left ventricle) accompanied by lv rupture.No infection was confirmed.According to the surgeon conducting the revision surgery, the explanting valve looks no problem at sight, but not sure of hidden issue and therefore he would like [manufacturer] to examine it in detail and provide an investigational report.".
|